Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gui-Ya Liao"'
Autor:
Wen-feng He, Xiao-bing Yang, Hong Deng, Yu-shu Zhou, Qiu-Ping Li, Shunqin Long, Zhen Xie, Baiming Zhao, Gui-ya Liao, WanYin Wu
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-9 (2018)
Trials
Trials
Background Cancer-related fatigue (CRF) is the most common symptom in patients with advanced non-small cell lung cancer (NSCLC) undergoing treatment with chemotherapy. However, evidence upon which to base management strategies is scarce. Traditional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f153ee27ebdaf1160d6602603dd08cc5
http://link.springer.com/article/10.1186/s13063-018-2845-7
http://link.springer.com/article/10.1186/s13063-018-2845-7
Autor:
Zong-Qi Pan, Wan-yin Wu, Hong Deng, Shujing Xiao, Wen-feng He, Gui-ya Liao, Xiao-shu Chai, Shunqin Long, Yu-shu Zhou, Xiao-bing Yang
Publikováno v:
Chinese Journal of Integrative Medicine. 24:734-740
To evaluate the effect of Fuzheng Kang’ai Formula (扶正抗癌方, FZKA) plus gefitinib in patients with advanced non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations. A randomized controlled trial was conducted from 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0c5290d3d9d9c54a68b0e2f9c0c4f00
https://doi.org/10.1007/s11655-017-2819-8
https://doi.org/10.1007/s11655-017-2819-8
Autor:
Shun-qin, Long, Xiao-xuan, Zhang, Xiao-bing, Yang, Yu-shu, Zhou, Wen-feng, He, Gui-ya, Liao, Yu-shu, Ouyang, Qiu-ping, Li, Jin-peng, Huang, Hong, Deng, Zong-qi, Pan, Shu-jing, Xiao, Jiao-zhi, Cai, Wan-yin, Wu
Publikováno v:
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 36(2)
To evaluate the clinical efficacy of Jianpi Liqi Yiliu Formula (JLYF) combined with cytokine-induced killer (CIK) cells for treating patients with advanced hepatocellular carcinoma (HCC).Between January 2011 and January 2014, 60 advanced HCC patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc683e6afb0e783a5e42fc6810abff3b
https://pubmed.ncbi.nlm.nih.gov/27078990
https://pubmed.ncbi.nlm.nih.gov/27078990
Autor:
Zong-Qi Pan, Jiao-zhi Cai, Shujing Xiao, Wen-feng He, WanYin Wu, Hong Deng, Gui-ya Liao, Shunqin Long, Xiao-bing Yang, Yu-shu Zhou, Qiu-Ping Li
Publikováno v:
Trials
Background Patients with advanced non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR) gene respond well to the EGFR tyrosine kinase inhibitor (TKI) gefitinib. Chinese herbal medicine (CHM) has been us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f930fa21928015dd396fd0bd66ddeccb
https://doi.org/10.1186/s13063-015-0685-2
https://doi.org/10.1186/s13063-015-0685-2
Autor:
Xiao-Bing, Yang, Shun-Qin, Long, Wan-Yin, Wu, Hong, Deng, Zong-Qi, Pan, Wen-Feng, He, Yu-Shu, Zhou, Gui-Ya, Liao
Publikováno v:
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 34(2)
To evaluate the prognostic factors in treating primary liver cancer (PLC) patients by Pi-strengthening and qi-regulating method (PSQRM), thus providing evidence and optimizing Pi-strengthening and qi-regulating program.Clinical data of 151 PLC patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3cdb9fbfa53c8e04a2773b2200223fb7
https://pubmed.ncbi.nlm.nih.gov/24672939
https://pubmed.ncbi.nlm.nih.gov/24672939
Autor:
Xiao-Bing, Yang, Xiao-Shu, Chai, Wan-Yin, Wu, Shun-Qin, Long, Hong, Deng, Zong-Qi, Pan, Wen-Feng, He, Yu-Shu, Zhou, Gui-Ya, Liao, Shu-Jing, Xiao
Publikováno v:
Chinese journal of integrative medicine. 24(10)
To evaluate the effect of Fuzheng Kang'ai Formula (, FZKA) plus gefitinib in patients with advanced non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations.A randomized controlled trial was conducted from 2009 to 2012 in Sou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dcf8772bb18a45ab177dce2c54157c8a
https://pubmed.ncbi.nlm.nih.gov/28795387
https://pubmed.ncbi.nlm.nih.gov/28795387
Autor:
Xiao-Bing, Yang, Shun-Qin, Long, Wan-Yin, Wu, Hong, Deng, Zong-Qi, Pan, Wen-Feng, He, Yu-Shu, Zhou, Gui-Ya, Liao, Yu-Shu, Ouyang, Qiu-Ping, Li, Li, Huang, Xue-Jun, Hu, Shu-Jing, Xiao, Jiao-Zhi, Cai
Publikováno v:
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 33(7)
To explore the distribution of Chinese medicine (CM) syndrome types in primary liver cancer (PLC) and their differences of the survival time.From May 2007 to March 2009, recruited were 151 PLC inpatients at Department of Tumor, Guangdong Provincial H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b24ab118e83bf7a94328938674097171
https://pubmed.ncbi.nlm.nih.gov/24063211
https://pubmed.ncbi.nlm.nih.gov/24063211
Autor:
Sai-man Chan, Xiao-bing Yang, Hong Deng, Shi-pu Shan, Wan-yin Wu, Liang-sheng Sun, Wen-feng He, Gui-ya Liao, Shunqin Long, Yu-shu Zhou
Publikováno v:
Chinese journal of integrative medicine. 16(5)
To observe the clinical efficacy and benefit response of extracorporeal high frequency thermotherapy (EHFT) combined with Chinese medicine (CM) in the treatment of patients with advanced nonsmall cell lung cancer. The study adopted a prospective, sma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09bc5f3ef5cded2055192116e12f21b5
https://pubmed.ncbi.nlm.nih.gov/20872115
https://pubmed.ncbi.nlm.nih.gov/20872115
Autor:
Xiao-Bing Yang, Wan-yin Wu, Shun-qin Long, Hong Deng, Zong-Qi Pan, Wen-Feng He, Yu-Shu Zhou, Gui-Ya Liao, Qiu-Ping Li, Shu-Jing Xiao, Jiao-Zhi Cai
Publikováno v:
Trials; 2015, Vol. 16 Issue 1, p1-6, 6p, 1 Diagram